{
    "report_title": "Industry Report on Animal Health Biotechnology",
    "report_date": "2023",
    "key_statistics": {
        "revenue": {
            "revenue_dollars": 13517000000,
            "revenue_cagr_historical": {
                "begin_year": 2004,
                "end_year": 2023,
                "revenue_cagr_value": -0.39
            },
            "revenue_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "revenue_cagr_value": 1.77
            }
        },
        "profit": {
            "profit_dollars": 1636000000,
            "profit_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "profit_cagr_value": -1.9
            },
            "profit_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "profit_cagr_value": null
            }
        },
        "profit_margins": {
            "profit_margins_percentage": 12.1,
            "profit_margins_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "profit_margins_cagr_value": -0.31
            },
            "profit_margins_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "profit_margins_cagr_value": null
            }
        },
        "industry_value_added": {
            "industry_value_added_dollars": 4832000000,
            "industry_value_added_cagr_historical": {
                "begin_year": 2004,
                "end_year": 2023,
                "industry_value_added_cagr_value": null
            },
            "industry_value_added_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "industry_value_added_cagr_value": null
            }
        },
        "employees": {
            "employees_count": 29343,
            "employees_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "employees_cagr_value": null
            },
            "employees_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "employees_cagr_value": null
            }
        },
        "wages": {
            "wages_dollars": 2875000000,
            "wages_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "wages_cagr_value": null
            },
            "wages_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "wages_cagr_value": null
            }
        },
        "imports": {
            "imports_dollars": 6243000000,
            "imports_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "imports_cagr_value": null
            },
            "imports_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "imports_cagr_value": null
            }
        },
        "exports": {
            "exports_dollars": 2037000000,
            "exports_cagr_historical": {
                "begin_year": 2005,
                "end_year": 2023,
                "exports_cagr_value": null
            },
            "exports_cagr_projected": {
                "begin_year": 2023,
                "end_year": 2029,
                "exports_cagr_value": null
            }
        }
    },
    "executive_summary": "Animal health biotechnology companies create products \u2013 vaccines, medications and food \u2013 that safeguard animals' health. Changing attitudes toward companion animals like dogs and cats encourage pet owners to pay premiums for these products. At the same, livestock producers see an invaluable benefit in biotech to protect their animals and investments. Innovative developments created by animal health biotechnology companies have shown the field's potential, leading investors to flock to animal health biotechnology companies.",
    "current_performance": [
        {
            "current_performance_point_title": "Animal Health Becomes Increasingly Important to Pet Owners and Livestock Producers",
            "current_performance_point_description": "As more pet owners view their pets as a part of the family, rising concerns about their well-being and healthcare have increased owners' willingness to spend on pet medications and vaccines. Animal health biotechnology companies are also increasingly developing products for livestock. Biotech products can safeguard herds from diseases and build resiliency to weather events and climate change."
        },
        {
            "current_performance_point_title": "Biotechnology Companies Resist the Pandemic's Disruption",
            "current_performance_point_description": "Despite COVID-19's widespread economic disruption, animal health biotechnology had one of its best years in 2020. While companies produce"
        },
        {
            "current_performance_point_title": "Rising Interest Rates Temper Investment in Animal Health Biotech",
            "current_performance_point_description": "Animal health biotechnology companies spend millions on research and development (R&D). Keeping up with sky-high R&D expenses can be difficult, but it is critical to developing proof of concept. Animal health biotechnology is more insulated from economic shocks than other fast-growing industries. Since biotechnology developments occur over the long term, companies are more resistant to business cycle fluctuations."
        },
        {
            "current_performance_point_title": "There Has Been a Growing Focus on Preventative Care",
            "current_performance_point_description": "Pet owners and livestock producers are becoming more focused on preventive care rather than treating diseases after they occur. This has increased demand for products and services that help keep animals healthy."
        }
    ],
    "future_outlook": [
        {
            "future_outlook_point_title": "A Higher Interest Rate Environment Will Threaten Biotech Performance",
            "future_outlook_point_description": "Animal health biotechnology companies will continue to rely on capital to fund research and development (R&D). But, a higher cost of capital could shift investment activity moving forward. Investors will be less risk-averse as interest rates rise, seeking safer and more secure investments in established biotech over early-stage companies."
        },
        {
            "future_outlook_point_title": "An Exciting Animal Health Market Will Attract New Companies",
            "future_outlook_point_description": "The animal health biotech industry is already competitive. The entrance of several new start-up companies could bring more competition into the space."
        },
        {
            "future_outlook_point_title": "Leading incumbents in animal health could pick up the pace of acquisitions",
            "future_outlook_point_description": "Leading incumbents in animal health could pick up the pace of acquisitions to temper competition. Acquisitions allow these companies to expand into new markets and diversify existing product lines, securing their position."
        },
        {
            "future_outlook_point_title": "C O M P A N I O N  A N I M A L S  W I L L  B E  T H E  F O R C E  B E H I N D  A N E X P A N D I N G  A N I M A L  H E A LT H  M A R K E T",
            "future_outlook_point_description": "Shifting consumer attitudes toward pets will continue to adjust pet owners' willingness to pay premium prices for biotech-produced animal food, vaccines and medications. Pet ownership will be at its highest rate, leading to a larger market for animal health companies developing companion animal products."
        },
        {
            "future_outlook_point_title": "T H E  D I G I T A L  T R A N S F O R M A T I O N  O F  T H E  A N I M A L  H E A LT H I N D U S T R Y  W I L L  A C C E L E R A T E",
            "future_outlook_point_description": "The digital transformation includes using new technologies, like artificial intelligence, machine learning, and big data, to improve animal health care. For example, AI-powered diagnostic tools are being developed to help veterinarians diagnose diseases more accurately and efficiently."
        }
    ],
    "industry_definition": "Animal health biotechnology companies research, develop, test and distribute therapeutic drugs, diagnostic tools and preventive products for livestock and companion animals. Drugs not developed using biological materials or processes are not included in this industry. In addition, companies provide tools that improve farm animal breeding programs.",
    "industry_impact": {
        "positive_impact_factors": [
            "low Capital Intensity Level",
            "high - steady Industry Assistance Level",
            "high - increasing Barriers To Entry Level"
        ],
        "negative_impact_factors": [
            "high Technology Change Level"
        ],
        "mixed_impact_factors": []
    },
    "swot_analysis": {
        "strengths": [
            "High & Increasing Barriers to Entry",
            "High & Steady Level of Assistance",
            "Growth Life Cycle Stage",
            "High Profit vs. Sector Average",
            "Low Product/Service Concentration",
            "Low Capital Requirements"
        ],
        "weaknesses": [
            "Medium Imports",
            "High Customer Class Concentration"
        ],
        "opportunities": [
            "High Revenue Growth (2018-2023)",
            "High Revenue Growth (2023-2028)",
            "High Performance Drivers",
            "Research and development expenditure"
        ],
        "threats": [
            "Very Low Revenue Growth (2005-2023)",
            "Low Outlier Growth",
            "Trade-weighted index"
        ]
    },
    "key_trends": [
        "Animal health biotech companies have a mounting role in safeguarding animal health. Pet owners and livestock producers are willing to pay a premium to improve the well-being of their animals.",
        "Animal health biotechnology relies on private investment to fund R&D",
        "Animal health biotechs navigate a complex regulatory environment",
        "Developments in vaccines and medications are transforming animal care",
        "Mid-Atlantic states are biotech hubs",
        "California's tech sector brings in animal health biotech companies",
        "Patent protection limits price competition",
        "Capital is vital for animal health biotech companies to fund long-term growth",
        "Zoetis is at the forefront of animal health",
        "Young, early-stage development animal health biotechs face more hurdles than established incumbents",
        "Animal health biotechnology R&D is a knowledge-intensive process"
    ],
    "market_segmentation": [
        {
            "segment": "Companion animals",
            "segment_description": "Companion animals (dogs, cats) are the largest market for animal health biotechnology companies. Main buyers include veterinary offices, pet stores and pet owners.",
            "segment_percentage": 51.3
        },
        {
            "segment": "Livestock",
            "segment_description": "Animal health biotechnology companies develop products for livestock producers and farmers to improve livestock's health, size and resiliency.",
            "segment_percentage": 45.2
        },
        {
            "segment": "Other",
            "segment_description": "Animal health biotechnology companies have been focusing on developing health products for animals like sheep, fish, horses, birds and bees.",
            "segment_percentage": 3.5
        }
    ],
    "products_and_services": [
        {
            "product_or_service": "Medications and Vaccines",
            "product_description": "Animal health biotechnology companies develop vaccines and medications for companion pets and livestock to fight infection and other common ailments. Vaccines and medications are the most lucrative products for animal health biotech companies.",
            "product_percentage": 57
        }
    ],
    "supply_chain": {
        "tier_1_suppliers": [
            "Inorganic Chemical Manufacturing in the US",
            "Organic Chemical Manufacturing in the US",
            "Glass Product Manufacturing in the US",
            "Scientific Research & Development in the US",
            "Plastic & Resin Manufacturing in the US"
        ],
        "tier_2_suppliers": [
            "Animal Health Biotechnology in the US"
        ],
        "tier_1_buyers": [
            "Beef Cattle Production in the US",
            "Dairy Farms in the US",
            "Chicken Egg Production in the US"
        ],
        "tier_2_buyers": [
            "Veterinary Services in the US",
            "Pet Stores in the US",
            "Livestock Production Support Services in the US"
        ]
    },
    "demand_determinants": [
        {
            "determinant_title": "Demand from Livestock Production Support Services",
            "determinant_description": "Farmers and livestock producers are the predominant consumers of animal health biotechnology products. Services supporting livestock production, like healthcare and feed quality analysis, are crucial in helping producers maintain their animals' health."
        },
        {
            "determinant_title": "Number of Pets (Cats and Dogs)",
            "determinant_description": "Trends in pet ownership influence demand for new pet products and treatments. As more consumers become pet owners, the need for vaccines, medication and pet food rises."
        }
    ],
    "international_trade": {
        "import_level": "Moderate",
        "import_trend": "Increasing",
        "export_level": "Moderate",
        "export_trend": "Increasing",
        "international_trade_points": [
            {
                "trade_title": "Ireland's Leading Position in Biotech Makes it a Top Exporter",
                "trade_description": "Ireland is a global leader in biotechnology, with the US importing nearly a quarter of all its biotechnology products from the country."
            },
            {
                "trade_title": "US Biotech Companies are Leading Exporters of Animal Vaccines",
                "trade_description": "Biotechnology companies in the US are one of the top exporters of biotech products globally. According to the Observatory of Economic Complexity, the US is a leading exporter of veterinary vaccines."
            }
        ]
    },
    "business_locations": [
        {
            "location": "Great Lakes",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "Mid-Atlantic",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "New England",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "Plains",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "Rocky Mountains",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "Southeast",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "Southwest",
            "location_description": "<UNKNOWN>",
            "percentage_establishments": 101,
            "percentage_population": 101
        },
        {
            "location": "West",
            "location_description": "California skews the distribution of animal health biotechnology companies in the West. California accounts for the highest share of establishments due to its large population, above-average income level, access to highly skilled labor and leading research universities.",
            "percentage_establishments": 0,
            "percentage_population": 10
        }
    ],
    "regulations_and_policies": {
        "regulations_level": "High",
        "regulations_trend": "Increasing",
        "regulations_points": [
            {
                "regulation_title": "THE UNITED STATES FOOD AND DRUG ADMINISTRATION",
                "regulation_description": "The United States Food and Drug Administration (FDA) regulates animal drugs, foods or biologics derived from bioengineered pharmaceutical plants for therapeutic, preventative or diagnostic use."
            },
            {
                "regulation_title": "CENTER FOR DRUG EVALUATION AND RESEARCH",
                "regulation_description": "The Center for Drug Evaluation and Research (CDER) monitors biotechnology companies through the Office of Biotechnology Products (OBP). The OBP reviews and regulates biological products and biosimilar biological products."
            },
            {
                "regulation_title": "THE ENVIRONMENTAL PROTECTION AGENCY",
                "regulation_description": "The Environmental Protection Agency regulates biotechnology companies through the Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)."
            },
            {
                "regulation_title": "US DEPARTMENT OF AGRICULTURE",
                "regulation_description": "The US Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) provides regulatory oversight for biotech products that pose risks to agriculture."
            }
        ]
    },
    "barriers_to_entry": {
        "barriers_level": "High",
        "barriers_trend": "Increasing",
        "barriers_points": [
            {
                "barrier_title": "Conducting company research and development activities",
                "barrier_description": "Requires dedicated teams of specialists thoroughly trained in their relevant fields of expertise."
            }
        ],
        "factors_increased_barrier": [
            "Technology Change"
        ],
        "factors_decreased_barrier": [
            "Capital Intensity",
            "Industry Assistance"
        ]
    },
    "basis_of_competition": {
        "basis_level": "Moderate",
        "basis_trend": "Increasing",
        "basis_points": [
            {
                "basis_title": "Patent protection limits price competition",
                "basis_description": "Biotechnology companies with patent protection receive market exclusivity for their product, granting them pricing power."
            },
            {
                "basis_title": "Capital is vital for animal health biotech companies",
                "basis_description": "Research and development can be a years-long process without any financial return."
            }
        ]
    },
    "market_share_concentration": {
        "concentration_level": "Moderate",
        "concentration_trend": "Unknown",
        "concentration_points": [
            {
                "concentration_title": "Skyrocketing research and development expenditures limit market share",
                "concentration_description": "Animal health biotechnology companies spend millions on research and development (R&D). Keeping up with sky-high R&D expenses can be difficult, but it is critical to developing proof of concept."
            },
            {
                "concentration_title": "Startups Struggle to Compete With Incumbents",
                "concentration_description": "Incumbent leaders in animal health dominate the industry. Leading companies have the capital to reinvest in research and development and spend on marketing, making it difficult for young, development-stage biotechs to compete."
            }
        ],
        "top_companies": [
            {
                "company_name": "Zoetis Inc.",
                "company_percentage": 26.3
            },
            {
                "company_name": "CH Boehringer Sohn AG & Ko. KG",
                "company_percentage": 7.2
            },
            {
                "company_name": "Merck & Co",
                "company_percentage": 7
            },
            {
                "company_name": "OTHERS",
                "company_percentage": 59.5
            }
        ]
    },
    "cost_structure_breakdown": [
        {
            "cost_type": "Profit",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Wages",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Purchases",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Depreciation",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Marketing",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Rent",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Utilities",
            "cost_type_percentage": 101
        },
        {
            "cost_type": "Other",
            "cost_type_percentage": 101
        }
    ],
    "cost_factors": [
        {
            "cost_factor_title": "Purchases",
            "cost_factor_description": "Animal health biotech companies purchase several inputs to research, develop, produce and market products. Purchases include lab equipment, medical supplies, and chemicals and reagents."
        }
    ],
    "capital_intensity": {
        "capital_intensity_level": "Low",
        "capital_intensity_points": [
            {
                "capital_intensity_title": "Conducting company research and development activities",
                "capital_intensity_description": "Conducting company research and development activities requires dedicated teams of specialists thoroughly trained in their relevant fields of expertise."
            },
            {
                "capital_intensity_title": "The major markets for this industry are highly concentrated",
                "capital_intensity_description": "The major markets for this industry are highly concentrated, which implies that the market has a focus on key customer segments. This presents an opportunity for strategic entrance into lower-end markets or unserved markets for innovations to take on a disruptive trajectory."
            }
        ],
        "capital_intensity_trend": "Unknown"
    },
    "revenue_volatility": {
        "volatility_level": "Moderate",
        "volatility_points": [
            {
                "volatility_title": "INVESTOR UNCERTAINTY CAN AFFECT CRUCIAL INVESTMENT",
                "volatility_description": "Biotech companies raise capital to push new products through research, development and market launch. However, a challenging funding environment can introduce significant volatility, potentially impacting progress."
            }
        ],
        "volatility_trend": "Unknown"
    },
    "technological_change": {
        "technological_change_level": "High",
        "technological_change_points": [
            {
                "technological_change_title": "THE DEVELOPMENT OF BIOTECH VACCINES AND MEDICATION",
                "technological_change_description": "Animal health biotechnology companies develop vaccines and medications for companion pets and livestock to fight infection and other common ailments. Vaccines and medications are the most lucrative products for animal health biotech companies."
            },
            {
                "technological_change_title": "ANTI-INFECTIVES ARE CRITICAL FOR LIVESTOCK PRODUCERS",
                "technological_change_description": "Although similar to vaccines, anti-infectives prevent or kill bacteria and fungi growth."
            },
            {
                "technological_change_title": "ANIMAL HEALTH BIOTECHNOLOGY COMPANIES CONTINUE TO INTRODUCE NEW ADVANCEMENTS",
                "technological_change_description": "Animal health biotechnology is a rapidly evolving field where companies continually develop new treatments and products."
            }
        ],
        "technological_change_trend": "Increasing"
    },
    "FAQs": [
        {
            "question": "How is your company affected by rising imports from abroad?",
            "answer": "Certain biotech products are only produced overseas."
        },
        {
            "question": "Are your company's sales heavily dependent on the health of the US economy?",
            "answer": "Industry revenue is largely driven by investment."
        },
        {
            "question": "Has your company explored acquisition opportunities in locations with well-established infrastructure networks?",
            "answer": "Some biotechnology companies purchase small companies to acquire patents."
        },
        {
            "question": "Is your company investing heavily in R&D to meet changing consumer preferences?",
            "answer": "Biotechnology companies must constantly invest in R&D to stay competitive."
        },
        {
            "question": "How is your company leveraging new technology in its operations?",
            "answer": "This industry is largely driven by technological development."
        },
        {
            "question": "Have you been able to reduce wage costs by automating operations over the past five years?",
            "answer": "Some biotech manufacturing processes can be automated using robots and cobots."
        },
        {
            "question": "How does your company ensure all health and safety requirements are met?",
            "answer": "Safety standards are particularly important for biopharmaceuticals used in livestock production."
        },
        {
            "question": "Do you work with trade associations or other interest groups to advance your company's interests?",
            "answer": "Biotechnology companies can fall under several categories allowing them to participate in various industry associations."
        },
        {
            "question": "How does your company's profit margins compare to your main competitors?",
            "answer": "Profit margins vary widely between different sized companies in this industry, but typically average around 10.0%."
        },
        {
            "question": "How frequently does your company purchase new equipment?",
            "answer": "New equipment enables companies to increase their research and development level."
        },
        {
            "question": "What proportion of your revenue is derived from donations and government funding? Can you raise revenue from other sources?",
            "answer": "Research and development of new products typically requires significant funding; therefore, it is essential for companies to acquire sufficient capital to finance product development."
        },
        {
            "question": "What issues does your organization support and promote? Are these issues of concern to a large group?",
            "answer": "Educating the public on the benefits and safety of biotechnology is essential to public acceptance and legislative change."
        },
        {
            "question": "Does your company keep up to date with the latest technology?",
            "answer": "The speedy adoption of new technological equipment and scientific techniques is essential to gaining a competitive advantage."
        },
        {
            "question": "What proportion of your revenue comes from dairy farmers? How have changes in dairy consumption influenced your demand?",
            "answer": "Rising dairy consumption increases revenue for dairy farmers, who are key buyers of industry products. As a result, growing demand for dairy products will likely lead dairy farmers to increase their demand for new biotechnology products to improve cattle and goat health."
        },
        {
            "question": "What proportion of your revenue comes from cattle and poultry farmers? Do you regularly target this market?",
            "answer": "Per capita meat consumption positively affects demand for diagnostic products, new vaccines and other biotechnology for livestock. When per capita meat consumption rises, buyers are better able to afford new medicines and disease-prevention methods."
        },
        {
            "question": "What proportion of your revenue is dedicated to research and development? What new technologies are you planning to introduce?",
            "answer": "Public and private spending on research and development (R&D) drives change in the Animal Health Biotechnology industry. R&D expenditure leads to improved identification of diseases, new vaccines and enhanced animal health."
        }
    ]
}